ArticlePloS one2025
The regulatory role of ZmSTOMAGEN1/2 in maize stomatal development is elucidated via gene editing and metabolic profiling.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stomatal development is mediated by EPIDERMAL PATTERNING FACTORs (EPFs), a family of secreted peptides including STOMAGEN/EPFL9 in Arabidopsis. To clarify the functional role of STOMAGEN orthologues in maize (Zea mays), we generated a double knockout mutant of ZmSTOMAGEN1 and ZmSTOMAGEN2 using CRISPR/Cas9 system. Comprehensive phenotypic analysis revealed that the zmstomagen1/2 mutant exhibited severe stomatal development defects, including complete absence of stomata between epidermal cells in stomatal lineage files and abnormal stomatal complexes with small lobed cells. These aberrant cells likely arose from failed asymmetric divisions of guard mother cells, ultimately preventing the formation of functional stomatal complexes. A double knockout of ZmSTOMAGEN1/2 reduced the expression of SPEECHLESS1 (SPCH1), MUTE, SCREAM2 (SCRM2), and STOMATAL DENSITY AND DISTRIBUTION1 (SDD1), impairing stomatal initiation and cell fate transition in early stomatal lineage cells. The mutant displayed a lower stomatal density and index, leading to reduced net photosynthetic rate, transpiration rate, and stomatal conductance but increased water-use efficiency (WUE). Compared to the wild-type plants (HiII-A × HiII-B), the zmstomagen1/2 mutant exhibited significant alterations in phytohormone homeostasis. These included brassinosteroid metabolite imbalance (increased typhasterol, decreased castasterone) and differential gibberellin regulation (elevated GA4, reduced GA1). These hormonal perturbations suggest that impaired stomatal morphogenesis in zmstomagen1/2 mutants result from disrupted crosstalk between multiple hormonals signaling networks. Our findings reveal a crucial role for ZmSTOMAGEN1/2 in regulating cell fate decisions within the stomatal lineage and provide a potential strategy for enhancing WUE in maize by manipulating ZmSTOMAGEN1/2 expression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.